The high levels of European secondary buyouts, where private equity firms buy assets from each other, are “not a sign of health”, according to Joseph Baratta, global head of private equity at Blackstone.

"Right now in Europe, something like 75% of deals above $500 million in enterprise value are sponsors selling to each other. That's not a sign of health in our market," Baratta told Tuesday's Bloomberg Dealmakers Summit in London